Basic V.sub.1 -vasopressin antagonists
US4604378A · kind A · utility
19Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 1984 |
| Grant date | Aug 5, 1986 |
| Priority date | — |
| Expiry date | Nov 21, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/15
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain vasopressin-like peptides, which have an acyclic unit at position 1 and which have an .omega.-amino- or guanidinoalkyl substituent attached to the cysteine in the 6-position of the ring, have V.sub.1 -vasopressin and oxytocin antagonist activity. A species of this series of new compounds is [1-desaminopenicillamine-2-(O-ethyl-D-tyrosine)-8-(1,4-diaminobutane)-9-de sglycinamide]-vasopressin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.